GNRs@mSiO2–HA–RGD (RGD: Arginine–glycine–aspartate) nanocarriers have been synthesized for targeting CD44- and integrin receptor-over-expressing cancer cells (SKOV-3). The gene discussed is CD44; the disease is cancer.